What Telehealth's Rapid Scaling Taught Us About Which Visits Actually Need a Room

For most of the history of outpatient medicine, the default assumption was simple: care requires presence. A patient shows up, sits in a waiting room, gets called back, and a clinician enters. The pandemic dismantled that assumption inside of a few weeks, and what grew in its place was not a clean replacement but a messier, more instructive picture of what physical presence actually does in a clinical encounter.

The scaling happened fast because it had to. Regulatory waivers loosened prescribing restrictions and cross-state licensure barriers. Payers, including Medicare, expanded reimbursement to cover synchronous video visits at rates closer to in-person. Clinicians who had never opened a video platform on a work device were suddenly doing ten appointments a day through one. What the system learned from that forced experiment is still being sorted out.

Some visit types held up well. Psychiatric medication management, talk therapy, chronic disease follow-up for stable patients, post-surgical check-ins where the surgeon mainly wants to see how someone is moving and ask about pain levels, care coordination calls for patients managing multiple conditions. These translated without obvious degradation in the hands of clinicians who adapted their intake questions to compensate for what they could not touch or smell or directly observe.

Other visit types exposed the limits quickly. A skin rash on a video call depends entirely on camera quality and lighting, and patient-held phones produce images that are genuinely diagnostic in some cases and misleading in others. Pediatric well visits involve weight, height, developmental screening that benefits from a trained observer in the room. Anything requiring auscultation, palpation, or a reliable blood pressure reading hit a wall that consumer-grade peripherals only partially lowered.

What the scaling period also revealed was a population-access split that complicated the simple narrative that telehealth democratizes care. Patients with reliable broadband, a private room, a smartphone or laptop, and the digital literacy to troubleshoot a dropped connection benefited substantially. Older patients, patients in rural areas with thin internet infrastructure, patients in crowded housing situations without a private space to discuss their symptoms, patients with hearing or vision impairments, patients who speak languages their providers do not, these groups often found telehealth a worse fit than the enthusiasm in press coverage suggested.

The reimbursement picture became the hinge everything else swung on. When payers covered telehealth at parity with in-person visits, health systems invested in platforms, trained staff, and built scheduling infrastructure. When coverage narrowed or parity rules sunset, utilization dropped in some specialties and held in others, particularly behavioral health, where patient preference and access barriers created durable demand independent of what any single payer decided.

What clinicians who lived through the scaling tend to say, when asked to be direct, is that telehealth is a good tool for a specific subset of clinical work, and that subset is larger than pre-pandemic assumptions allowed but smaller than the technology industry's projections implied. A follow-up visit for a well-controlled diabetic patient who lives an hour from the nearest endocrinologist is a strong candidate. A first visit for chest pain is not.

The lasting structural shift is probably this: the question is no longer whether a visit can be virtual, but whether this patient, with this clinical problem, at this point in their care, is better served in a room or through a screen. That is a clinical judgment, and it should be made by clinicians, not by platform adoption curves.